Oxybate

CHEMBL1342 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
104.1 g/mol
LogP
-0.6
Phase
4

The salt form of gamma-hydroxybutyrate (GHB) used medically to treat narcolepsy, specifically reducing episodes of cataplexy and excessive daytime sleepiness. It works as a central nervous system depressant and is administered at night due to its sedative properties.

分子量

104.1000 g/mol

LogP

-0.60

TPSA

57.50 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)CCCO

InChI

InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)

Molecular Formula

C4H8O3

HBD / HBA

2 / 3

回転可能結合数

3

重原子数

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The salt form of gamma-hydroxybutyrate (GHB) used medically to treat narcolepsy, specifically reducing episodes of cataplexy and excessive daytime sleepiness. It works as a central nervous system depressant and is administered at night due to its sedative properties.

Yes, Oxybate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1342. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10413. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.